CIRCULAVEEL FILM-COATED TABLETS
How to use CIRCULAVEEL FILM-COATED TABLETS
Translated with AI
This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.
Show originalContents of the leaflet
Introduction
PACKAGE LEAFLET
Package Leaflet: Information for the Patient
Circulaveel Film-Coated Tablets
Dry extract of Vitis viniferaL. (dry extract of red grape leaves)
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist exactly.
- Keep this package leaflet, as you may need to read it again.
- If you need advice or more information, consult your pharmacist.
- If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. See section 4.
- You should consult a doctor if your symptoms worsen or do not improve after two weeks.
Contents of the Package Leaflet
- What Circulaveel Film-Coated Tablets are and what they are used for
- What you need to know before taking Circulaveel
- How to take Circulaveel
- Possible side effects
- Storage of Circulaveel
Contents of the pack and further information
1. What Circulaveel Film-Coated Tablets are and what they are used for
Circulaveel Film-Coated Tablets are a herbal medicinal product for the treatment of adults with symptoms of chronic venous insufficiency, such as swollen legs, feeling of heaviness, pain, fatigue, itching, tension, and cramps in the back of the legs.
2. What you need to know before taking Circulaveel
Do not takeCirculaveel:
If you are allergic to red grape leaf extract (Vitis viniferaL) or to any of the other components of this medication (listed in section 6).
Warnings and precautions
Consult your doctor or pharmacist before starting to take Circulaveel.
Consult your doctor immediately if skin inflammation or ulcers, thrombophlebitis, or subcutaneous induration (hardening of tissues under the skin), severe pain, ulcers, sudden swelling of one or both legs, heart or kidney failure appear.
Other non-invasive actions recommended by the doctor, such as compressive bandaging of the legs, wearing compression stockings, or taking cold water baths, should be strictly followed.
In the case of an inadequate or unsatisfactory symptomatic response within 2 weeks, a doctor should be consulted, as edema or other symptoms may have other causes.
If your symptoms worsen, consult your doctor or pharmacist.
Children and adolescents
The use of Circulaveel is not recommended in children and adolescents under 18 years of age.
Taking Circulaveel with other medications
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
Taking Circulaveel with food and drinks
No interactions are expected.
Pregnancy and breast-feeding
Pregnancy
Circulaveel should not be used during pregnancy. There are no sufficient data on the use of grape leaf extract in pregnant women.
Breast-feeding
Circulaveel should not be used during breast-feeding, as there is not enough information on the excretion of grape leaf extract in breast milk.
If you are pregnant or breast-feeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and using machines
No studies have been conducted on the effect on the ability to drive and use machines. However, it is unlikely to affect driving ability or machine operation.
3. How to take Circulaveel
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist exactly. In case of doubt, ask your doctor or pharmacist.
The recommended dose is:
Adults and elderly: 1-2 tablets per day, with water, before breakfast.
The score line is only for breaking the tablet if you find it difficult to swallow it whole.
The recommended duration of treatment with Circulaveel is 12 weeks. It may take 2-3 weeks of treatment before beneficial effects are observed.
Long-term treatments can be performed after consulting a doctor.
Use in children and adolescents
The use of Circulaveel is not recommended in children and adolescents under 18 years of age.
If you take more Circulaveel than you should
If you have taken more than the recommended dose, consult your doctor or pharmacist and bring this package leaflet with you. You can also call the Toxicology Information Service, phone 915 620 420.
If you forget to take Circulaveel
Do not take a double dose to make up for forgotten doses, but continue taking your usual dose at the usual time.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
4. Possible side effects
Like all medications, this medication can cause side effects, although not everyone experiences them.
Skin hypersensitivity reactions (itching, erythema, urticaria) of unknown frequency may occur after taking Circulaveel.
Additionally, nausea, gastrointestinal discomfort, and headache may occur. The frequency is unknown.
If you experience side effects, consult your doctor or pharmacist. This includes any side effects not listed in this package leaflet.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Medicines Monitoring System: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medication.
5. Storage of Circulaveel
Keep this medication out of the sight and reach of children.
This medication should not be stored above 30°C, and the tablets should be kept in the original packaging (in the blister pack).
Do not use this medication after the expiration date shown on the carton and blister pack after "EXP". The expiration date is the last day of the month indicated.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and any unused medication in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
6. Contents of the pack and further information
Composition of Circulaveel
- The active ingredient is dry extract of Vitis viniferaL., folium (grape leaves) (4-6:1), extraction solvent: water.
- 1 film-coated tablet contains 360 mg of dry extract of Vitis viniferaL. (grape leaves)
- The other ingredients are: Microcrystalline cellulose, Maltodextrin, Hypromellose, Sodium croscarmellose, Anhydrous colloidal silica, Crospovidone, Vegetable magnesium stearate, Talc, Titanium dioxide E171, Macrogol 6000 (polyethylene glycol), Iron oxide red E172.
Appearance of the product and pack contents
Circulaveel are oblong film-coated tablets with a reddish-brown color and a score line on both sides.
They are available in blister packs of 30, 60, and 90 film-coated tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Laboratorios Heel España, S.A.U.
Calle Madroño, s/n 28770
Colmenar Viejo (Madrid)
Phone: 918473910
Fax: 918463614
Manufacturer:
Wiewelhove GmbH
Dörnebrink 19
49479 Ibbenbüren
Germany
Date of the last revision of this package leaflet:December 2019
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).
- Country of registration
- Prescription requiredNo
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to CIRCULAVEEL FILM-COATED TABLETSDosage form: MODIFIED-RELEASE CAPSULE, 50 mg escinActive substance:Manufacturer: Glenwood Gmbh Pharmazeutische ErzeugnissePrescription requiredDosage form: TABLET, 500 mgActive substance: diosmin, combinationsManufacturer: Laboratorios Servier S.L.Prescription not requiredDosage form: TABLET, 500 mgActive substance: diosmin, combinationsManufacturer: Towa Pharmaceutical S.A.Prescription not required
Online doctors for CIRCULAVEEL FILM-COATED TABLETS
Discuss questions about CIRCULAVEEL FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Frequently Asked Questions